DongKook Pharmaceutical Co., Ltd.
086450.KQFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
609
Cost of Revenue
273
Gross Profit
336
Gross Margin
55.1%
Operating Income
60
Operating Margin
9.9%
Net Income
46
Net Margin
7.5%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
86
EBITDA Margin
14.2%
2023
12/31/2023
Revenue
548
Cost of Revenue
244
Gross Profit
304
Gross Margin
55.4%
Operating Income
50
Operating Margin
9.1%
Net Income
35
Net Margin
6.5%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
67
EBITDA Margin
12.1%
2022
12/31/2022
Revenue
496
Cost of Revenue
215
Gross Profit
281
Gross Margin
56.7%
Operating Income
55
Operating Margin
11.2%
Net Income
40
Net Margin
8.0%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
68
EBITDA Margin
13.8%
2021
12/31/2021
Revenue
446
Cost of Revenue
186
Gross Profit
259
Gross Margin
58.2%
Operating Income
47
Operating Margin
10.6%
Net Income
38
Net Margin
8.5%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
67
EBITDA Margin
15.0%
2020
12/31/2020
Revenue
419
Cost of Revenue
169
Gross Profit
251
Gross Margin
59.7%
Operating Income
64
Operating Margin
15.2%
Net Income
42
Net Margin
10.0%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
72
EBITDA Margin
17.3%